Tiffany Mignerey
Family · Cincinnati, OHNPI 1396337895
Payments from drug & device makers
Across 115 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$691
- AstraZeneca$478
- Novo Nordisk$198
- Lilly USA, LLC$110
- Takeda Pharmaceuticals U.S.A., Inc.$74
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$67
- plus $482 from 13 others
What the payments were for
- Food & beverage$2,101100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $691 |
| AstraZeneca | 21 | $478 |
| Novo Nordisk | 12 | $198 |
| Lilly USA, LLC | 7 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $67 |
| Pfizer | 4 | $66 |
| Axsome Therapeutics, Inc. | 2 | $64 |
| Gilead | 2 | $55 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $49 |
| Amgen | 3 | $42 |
| Cepheid | 1 | $29 |
| Electromed, Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Organon | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,101 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $44,486 |
| FarxigaDapagliflozin Propanediol | 35 | $33,416 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $22,831 |
| JardianceEmpagliflozin | 25 | $21,948 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $16,767 |
| MounjaroTirzepatide | 11 | $13,047 |
| Spiriva HandihalerTiotropium Bromide | 19 | $9,559 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $3,440 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $3,337 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $1,629 |
| Atorvastatin Calcium | 174 | $1,063 |
| Omeprazole | 90 | $745 |
| Gabapentin | 87 | $718 |
| Duloxetine Hcl | 20 | $569 |
| Levothyroxine Sodium | 62 | $505 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $478 | $59,58480 claims |
| Novo NordiskOzempic | $198 | $44,48645 claims |
| Lilly USA, LLCMounjaro | $110 | $13,04711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.
Other family in Cincinnati
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Lindsey SpencerCincinnati$53K
- Bria BarjucaCincinnati$38K
- Jillian CowanCincinnati$20K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.